Schwarz F, Arefian H, Hartmann M, Runnebaum I, et al. Correction: Cost-effectiveness of talazoparib for patients with locally advanced or metastasized breast cancer in Germany. PLoS One 2024;19:e0303776.
PMID: 38722867